January 14, 2025 · Form 4 insider transaction
Pinnow Cole bought 43,750 shares of Cogent Biosciences, Inc. at $7.60 per share, a transaction worth $332.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $7.53 to $7.60. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.; Includes an aggregate of 1,398 shares acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan on December 31, 2024.